Solicitation
Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak
75F40126Q00327
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
$349,994.70 obligated so far on USAspending
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2026
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- AMPLICON SEQUENCING SERVICES
US Geological Survey, Ofc of Acquisition Grants-Denver
SolicitationNAICS 541714Location not published140G0226Q0047Closes in 4 daysNov 5 - High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PA-27-01Closes in 5 daysNov 5 - Firefox
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PS-26-137Closes in 9 daysNov 9
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
Title: Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak
Questions: 08/07/26
Responses Due: 08/10/26
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Pricing Sheet.xlsx25 KB, August 4, 2026
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- University of Liverpool
- UEI
- VFHSMEHGFGG5
- CAGE
- U5F53
- Vendor location
- Liverpool
- Contract
- 75F40126C00106, definitive contract
- Obligated
- $349,994.70
- Actions
- 1 between September 2, 2026 and September 2, 2026
- Competition
- Not Competed, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Eo 14398 - This Project Shall Sequence and Characterize the Genome of BDBV in the Current Outbreak, with a Specific Target to Sequence and Analyze the BDBV Genome from as Many as 1,000 Patients
- Match
- solicitation number 75F40126Q00327 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 4, 2026
Solicitation
Due August 10, 2026 at 12:00 PM EDT. SAM.gov, notice 630d874ac1f6410ca4289d1b85a3d809
1 revisions on SAM
- August 4, 2026: publish, solicitation
Points of contact
- Ryan Alexanderryan.alexander@fda.hhs.gov